|
U.S. Needs to Better Monitor, Protect Overseas Patents, Lawmakers Told
Congress and the U.S. Trade Representative need to do more to protect American biopharma patents abroad, a drugmaker told lawmakers Thursday.
This article is viewable by subscribers only. To view this article, please select an option below.
|
|
Subscribe
Archives